MORELLI, MICAELA

MORELLI, MICAELA  

Mostra records
Risultati 1 - 20 di 156 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autore(i) File
Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice 1-gen-2023 Costa, Giulia; Serra, Marcello; Maccioni, Riccardo; Casu, MARIA ANTONIETTA; B Kasture, Sanjay; Acquas, Elio; Morelli, Micaela
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson's disease 1-gen-2022 Parekh P.; Serra M.; Allaw M.; Perra M.; Marongiu J.; Tolle G.; Pinna A.; Casu M.A.; Manconi M.; Caboni P.; Manzoni O.J.J.; Morelli M.
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice 1-gen-2021 Costa G.; Spulber S.; Paci E.; Casu M.A.; Ceccatelli S.; Simola N.; Morelli M.
Involvement of the protein ras homolog enriched in the striatum, rhes, in dopaminergic neurons' degeneration: Link to parkinson's disease 1-gen-2021 Serra, Marcello; Pinna, Annalisa; Costa, Giulia; Usiello, Alessandro; Pasqualetti, Massimo; Avallone, Luigi; Morelli, Micaela; Napolitano, Francesco
Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT<inf>1A/1B</inf> receptor agonist and A<inf>2A</inf> receptor antagonist 1-gen-2021 Pinna, Annalisa; Costa, Giulia; Serra, Marcello; Contu, Liliana; Morelli, Micaela
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson's Disease 1-gen-2020 Costa G.; Sisalli M.J.; Simola N.; Della Notte S.; Casu M.A.; Serra M.; Pinna A.; Feliciello A.; Annunziato L.; Scorziello A.; Morelli M.
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls 1-gen-2020 Costa G.; Serra M.; Marongiu J.; Morelli M.; Simola N.
Pharmacological interactions between adenosine A<inf>2A</inf> receptor antagonists and different neurotransmitter systems 1-gen-2020 Pinna, Annalisa; Serra, Marcello; Marongiu, Jacopo; Morelli, Micaela
Combined administration of dopaminergic and nondopaminergic drugs reverses neuroinflammation in a rat model of parkinson's disease 1-gen-2019 Costa, G.; Serra, M.; Morelli, M.; Pinna, A.
Fos expression induced by olanzapine and risperidone in the central extended amygdala 1-gen-2019 Pinna, A; Costa, G; Contu, L; Morelli, M
Lack of rhes increases mdma-induced neuroinflammation and dopamine neuron degeneration: Role of gender and age 1-gen-2019 Costa G.; Porceddu P.F.; Serra M.; Casu M.A.; Schiano V.; Napolitano F.; Pinna A.; Usiello A.; Morelli M.
Neurofarmacologia nel trattamento della Malattia di Parkinson e nuovi approcci farmacologici 1-gen-2019 Pinna, Annalisa; Morelli, Micaela
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A(2A) receptor antagonist 1-gen-2019 Pinna, A; Costa, G; Serra, M; Morelli, M
Modulation of Rat 50-kHz Ultrasonic Vocalizations by Glucocorticoid Signaling: Possible Relevance to Reward and Motivation 1-gen-2018 Simola N.; Paci E.; Serra M.; Costa G.; Morelli M.
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity 1-gen-2018 Costa G.; Morelli M.; Simola N.
Rhes counteracts dopamine neuron degeneration and neuroinflammation depending on gender and age 1-gen-2018 Costa G.; Pinna A.; Porceddu P.F.; Casu M.A.; Di Maio A.; Napolitano F.; Usiello A.; Morelli M.
Role of adenosine A(2A) receptors in motor control: relevance to Parkinson's disease and dyskinesia 1-gen-2018 Pinna, A; Serra, M; Morelli, M; Simola, N
A novel therapeutic strategy for the prevention of the onset of dyskinesia in the therapy of Parkinson's disease 1-gen-2017 Pinna A; Costa G; Contu L; Serra M; Simola N; Carta M; Morelli M.
A novel therapeutic strategy to prevent the onset of dyskinesia in models of Parkinson's disease: acute and chronic studies. 1-gen-2017 Pinna A; Costa G; Contu L; Serra M; Simola N; Carta M; Morelli M;.
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms 1-gen-2017 Moratalla, R; Khairnar, A; Simola, N; Granado, N; Garciamontes, Jr; Porceddu, Pf; Tizabi, Y; Costa, G; Morelli, M